Stocks and Investing
Stocks and Investing
Tue, March 1, 2022
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
Puneet Souda Maintained (VCYT) at Buy with Decreased Target to $40 on, Mar 1st, 2022
Puneet Souda of SVB Leerink, Maintained "Veracyte, Inc." (VCYT) at Buy with Decreased Target from $45 to $40 on, Mar 1st, 2022.
Puneet has made no other calls on VCYT in the last 4 months.
There is 1 other peer that has a rating on VCYT. Out of the 1 peers that are also analyzing VCYT, 0 agree with Puneet's Rating of Hold.
This is the rating of the analyst that currently disagrees with Puneet
- Mason Carrico of "Stephens & Co." Initiated at Buy and Held Target at $52 on, Friday, January 7th, 2022
Contributing Sources